
Keywords: E2; 17β-estradiol; FAS; fatty acid synthase; HDL; high-density lipoproteins; HRT; hormone replacement therapy; ISOs; isoflavones; LDL; low-density lipoproteins; OVX; ovariectomized; PGC; peroxisome proliferator-activated receptor-γ coactivator; PND; pos